Novo Nordisk A/S
NVO
$160.76
$2.911.84%
| Weiss Ratings | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | A+ | |||
| Rating Factors | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Excellent | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.59 | |||
| Price History | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.03% | |||
| 30-Day Total Return | -5.70% | |||
| 60-Day Total Return | 14.43% | |||
| 90-Day Total Return | 17.55% | |||
| Year to Date Total Return | 18.05% | |||
| 1-Year Total Return | 44.70% | |||
| 2-Year Total Return | 101.96% | |||
| 3-Year Total Return | 158.92% | |||
| 5-Year Total Return | 267.70% | |||
| 52-Week High % Change | -8.74% | |||
| 52-Week Low % Change | 66.12% | |||
| Price | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $172.97 | |||
| 52-Week Low Price | $95.02 | |||
| 52-Week Low Price (Date) | Sep 26, 2022 | |||
| 52-Week High Price (Date) | Apr 21, 2023 | |||
| Valuation | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | $348.73B | |||
| Enterprise Value | 348.40B | |||
| Price/Earnings (TTM) | 45.59 | |||
| Earnings Per Share (TTM) | 3.46 | |||
| Earnings Per Share Growth | 4.84% | |||
| Price/Earnings To Growth | 9.44 | |||
| Price/Sales (TTM) | 14.26 | |||
| Price/Book (Q) | 29.61 | |||
| Enterprise Value/Revenue (TTM) | 13.92 | |||
| Price | $160.76 | |||
| Enterprise Value/EBITDA (TTM) | 29.89 | |||
| Enterprise Value/EBIT | 32.52 | |||
| Market Cap Category | Mega Cap | |||
| Dividends and Shares | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.261B | |||
| Dividend Yield | 0.79% | |||
| Div. Per Share (Most Recent) | $0.85 | |||
| Dividend Per Share (TTM) | $1.25 | |||
| Payout Ratio (TTM) | 46.63% | |||
| Dividend Per Share (Most Recent) | $0.85 | |||
| Company Info | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 45 44 44 88 88 | |||
| Address | -- | |||
| Website | www.novonordisk.com | |||
| Country | Denmark | |||
| Year Founded | 1923 | |||
| Profitability | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 42.81% | |||
| Profit Margin | 31.44% | |||
| Management Effectiveness | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 20.79% | |||
| Return on Equity | 68.97% | |||
| Income Statement | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | $25.03B | |||
| Total Revenue (TTM) | $25.03B | |||
| Revenue Per Share | $11.07 | |||
| Gross Profit (TTM) | $21.00B | |||
| EBITDA (TTM) | $11.66B | |||
| EBIT (TTM) | $10.71B | |||
| Net Income (TTM) | $7.87B | |||
| Net Income Avl. to Common (TTM) | $7.87B | |||
| Total Revenue Growth (Q YOY) | 12.09% | |||
| Earnings Growth (Q YOY) | 11.49% | |||
| EPS Diluted (TTM) | $3.46 | |||
| EPS Diluted Growth (Q YOY) | 12.92% | |||
| Balance Sheet | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $3.39B | |||
| Cash Per Share (Q) | $1.50 | |||
| Total Current Assets (Q) | $15.55B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | $12.00B | |||
| Current Ratio (Q) | 0.895 | |||
| Book Value Per Share (Q) | $5.33 | |||
| Total Assets (Q) | $34.66B | |||
| Total Current Liabilities (Q) | $17.38B | |||
| Total Debt (Q) | $3.70B | |||
| Total Liabilities (Q) | $22.67B | |||
| Total Common Equity (Q) | $12.00B | |||
| Cash Flow | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$3.46B | |||
| Cash from Financing (TTM) | -$7.41B | |||
| Net Change in Cash (TTM) | $344.83M | |||
| Levered Free Cash Flow (TTM) | $8.27B | |||
| Cash from Operations (TTM) | $11.25B | |||
